Ursodeoxycholic acid

CAS : 128-13-2

Ref. 3D-FU09676

Informations sur le produit

• Nom: Ursodeoxycholic acid
• Synonymes: UDCAUrsodiol3a,7b-Dihydroxy-5b-cholan-24-oic acid, (3α,5β,7β)-3,7-Dihydroxycholan-24-oic acid, 17β-(1-Methyl-3-carboxypropyl)etiocholane-3α,7β-diol, 3α,7β-Dihydroxy-5β-cholan-24-oate, 3α,7β-Dihydroxy-5β-cholan-24-oic acid, 3α,7β-Dihydroxy-5β-cholanic acid, 3α,7β-Dihydroxy-5β-cholanoic acid, 3α,7β-Dihydroxycholanic acid, 5β-Cholan-24-oic acid, 3α,7β-dihydroxy-, 5β-Cholanic acid, 3α,7β-dihydroxy-, 7β-Hydroxylithocholic acid, Acide Ursodesoxycholique, Acido Ursodeoxicolico, Actigall, Adursal, Arsacol, CHOLON-24-OIC ACID, 3,7-DIHYDROXY-(3α, 5β, 7.β)-, Cholit-Ursan, Delursan, Desocol, Desol, Destolit, Deursil, Litursol, Lyeton, Nsc 683769, Paptarom, Solutrat, Udca, Urdes, Urosiol, Ursacol, Ursic acid, Urso, Ursobilin, Ursochol, Ursocholic acid, deoxy-, Ursocol, Ursodamor, Ursodeoxycholic Acid, Ursodeoxycholsaure, Ursodesoxycholic acid, Ursodiol, Ursofalk, Ursogall, Ursolvan, Ursosan, (4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid, 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol, (4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, (3alpha,5alpha,7beta)-3,7-dihydroxycholan-24-oate, (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oate, 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid, (3alpha,5beta,7beta,8xi,9xi,14xi)-3,7-dihydroxycholan-24-oic acid, Cholan-24-oic acid, 3,7-dihydroxy-, (3α,5β,7β)-, (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid, 3,7-Dihydroxycholan-24-oic acid

Description

Ursodeoxycholic acid is a bile acid that has been used for the treatment of primary sclerosing cholangitis and other bowel diseases. It is also used in the treatment of gallstones, liver disease, and to prevent liver damage from drugs such as acetaminophen. Ursodeoxycholic acid has been shown to have anti-inflammatory properties by inhibiting signal pathways that are responsible for inflammation. This drug may be beneficial in treating inflammatory bowel disease. Ursodeoxycholic acid can be administered orally or intravenously, but intravenous administration must be done slowly to avoid an adverse reaction. Ursodeoxycholic acid is typically administered as a low-dose group with a rate constant of 3 hours.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 392.57 g/mol
• Formule: C₂₄H₄₀O₄
• Couleur/Forme: Powder